Eeg Software, LLC

Eeg Software, LLC specializes in biofeedback system application software, specifically for EEG (electroencephalography) data analysis. Their products, such as EEGer4 and EEGER4 Model 4.3, are designed to process and interpret brainwave activity in real-time, supporting clinical or research applications like therapeutic or diagnostic monitoring. These are software-based tools rather than physical hardware.

Eeg Software, LLC is based in the United States. Since the company operates within the U.S., its devices fall under FDA (Food and Drug Administration) regulatory oversight. The FDA classifies their biofeedback software as Class II devices, which requires compliance with specific regulatory pathways like 510(k) clearance and UDI (Unique Device Identifier) requirements to ensure safety and effectiveness.

Eeg Software, LLC’s devices are authorised through the FDA’s 510(k) clearance process and are also listed under the FDA’s Unique Device Identifier (UDI) system. These registries ensure traceability and compliance with U.S. medical device regulations, helping healthcare providers and regulators verify the authorised status of products like EEGer4 and EEGER4 Model 4.3.

Eeg Software, LLC’s biofeedback system application software, such as EEGer4 and EEGER4 Model 4.3, is classified as FDA Class II devices. This classification is based on the level of risk associated with the product—Class II devices pose moderate risk and require special controls beyond general controls to ensure their safety and performance. The FDA mandates compliance with specific regulatory pathways, such as 510(k) clearance, to maintain authorisation.